LISA TRACKER®, the leading biotherapy monitoring range available in the global marketCroissy-Beaubourg and Montpellier, December 1, 2016 – Theradiag (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specializing in…
Croissy-Beaubourg and Montpellier, November 28, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, has announced that it has won the “Exporter” award from the Ile de France Chamber…
Croissy-Beaubourg and Montpellier, October 10, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that a systematic review of the pharmaco-economic studies published in the Journal…